BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 31948982)

  • 1. Successful liver transplantation for drug-induced vanishing bile duct syndrome.
    Hashim A; Barnabas A; Miquel R; Agarwal K
    BMJ Case Rep; 2020 Jan; 13(1):. PubMed ID: 31948982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic-associated acute vanishing bile duct syndrome: a pattern associated with severe, prolonged, intrahepatic cholestasis.
    Davies MH; Harrison RF; Elias E; Hübscher SG
    J Hepatol; 1994 Jan; 20(1):112-6. PubMed ID: 8201211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flucloxacillin induced liver disease: histopathological findings at biopsy and autopsy.
    Eckstein RP; Dowsett JF; Lunzer MR
    Pathology; 1993 Jul; 25(3):223-8. PubMed ID: 8265236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vanishing bile duct syndrome with hyperlipidemia after ibuprofen therapy in an adult patient: a case report.
    Xie W; Wang Q; Gao Y; Pan CQ
    BMC Gastroenterol; 2018 Sep; 18(1):142. PubMed ID: 30268094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flucloxacillin induced delayed cholestatic hepatitis.
    Miros M; Kerlin P; Walker N; Harris O
    Aust N Z J Med; 1990 Jun; 20(3):251-3. PubMed ID: 2372276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hepatic transplantation for severe ductopenia related to ingestion of thiabendazole].
    Skandrani K; Richardet JP; Duvoux C; Cherqui D; Zafrani ES; Dhumeaux D
    Gastroenterol Clin Biol; 1997; 21(8-9):623-5. PubMed ID: 9587501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cloxacillin-induced acute vanishing bile duct syndrome: A case study and literature review.
    Faragalla K; Lau H; Wang HL; Liu J
    Br J Clin Pharmacol; 2022 Oct; 88(10):4633-4638. PubMed ID: 35730139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vanishing bile duct syndrome related to DILI and Hodgkin lymphoma overlap: A rare and severe case.
    Greca RD; Cunha-Silva M; Costa LBE; Costa JGF; Mazo DFC; Sevá-Pereira T; Nascimento MMC; Pereira IE; Oliveira FC; Faria GAS; Neto FLP; Almeida JRS
    Ann Hepatol; 2020; 19(1):107-112. PubMed ID: 31537508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sertraline-Associated Cholestasis and Ductopenia Consistent with Vanishing Bile Duct Syndrome.
    Conrad MA; Cui J; Lin HC
    J Pediatr; 2016 Feb; 169():313-5.e1. PubMed ID: 26597434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meropenem-induced vanishing bile duct syndrome.
    Schumaker AL; Okulicz JF
    Pharmacotherapy; 2010 Sep; 30(9):953. PubMed ID: 20812433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flucloxacillin-induced liver injury.
    Andrews E; Daly AK
    Toxicology; 2008 Dec; 254(3):158-63. PubMed ID: 18793693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Vanishing bile duct syndrome following allogeneic bone marrow transplantation].
    Aliani S; Meyer S; Krenn T; Müller-Molaian I; Graf N
    Klin Padiatr; 2002; 214(6):371-4. PubMed ID: 12424687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe ductopenia and cholestasis from levofloxacin drug-induced liver injury: a case report and review.
    Levine C; Trivedi A; Thung SN; Perumalswami PV
    Semin Liver Dis; 2014 May; 34(2):246-51. PubMed ID: 24879988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Drug-induced bile duct injury: progress and challenges].
    Li DL
    Zhonghua Gan Zang Bing Za Zhi; 2023 Apr; 31(4):339-344. PubMed ID: 37248973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flucloxacillin and cholestatic hepatitis.
    Jick H; Derby LE; Dean AD; Henry DA
    Med J Aust; 1994 Apr; 160(8):525. PubMed ID: 8170433
    [No Abstract]   [Full Text] [Related]  

  • 16. Prolonged hepatic cholestasis after flucloxacillin therapy.
    Turner IB; Eckstein RP; Riley JW; Lunzer MR
    Med J Aust; 1989 Dec 4-18; 151(11-12):701-5. PubMed ID: 2593915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathologic features of drug-induced vanishing bile duct syndrome].
    Ye LH; Wang CK; Zhang HC; Liu ZQ; Zheng HW
    Zhonghua Gan Zang Bing Za Zhi; 2017 Apr; 25(4):317-320. PubMed ID: 28494557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vanishing bile-duct syndrome following liver transplantation--is it reversible?
    Hubscher SG; Buckels JA; Elias E; McMaster P; Neuberger J
    Transplantation; 1991 May; 51(5):1004-10. PubMed ID: 1851580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case of Vanishing Bile Duct Syndrome after Drug-Induced Liver Injury Caused by Pelubiprofen.
    Bak H; Kim H; Lee S; Lee Y; Bang SM; Lee YS
    Yonsei Med J; 2020 Dec; 61(12):1060-1063. PubMed ID: 33251781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful Living-Donor Liver Transplantation for Cholestatic Liver Failure Induced by Allopurinol: Case Report.
    Imai H; Kamei H; Onishi Y; Yamada K; Ishizu Y; Ishigami M; Goto H; Ogura Y
    Transplant Proc; 2015 Nov; 47(9):2778-81. PubMed ID: 26680093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.